While the full promise of genomic medicine may be many years in the future, personalized health care (PHC) can begin solving important health care needs now and provide a framework for the adoption of genomic technologies as they are validated. PHC is a strategic approach to medicine that is individualized, predictive, preventive, and involves intense patient engagement. There is great need for more effective models of care as nearly half of Medicare patients age 65 and older have three or more preventable chronic conditions and account for 89% of Medicare’s growing expenditures. With its focus on reactive care, the current health care system is not designed to effectively prevent disease nor manage patients with multiple chronic conditions. PHC may be a solution for improving care for this population and therefore has been adopted as the delivery platform along with a new personalized health plan tool for 230 multi-morbid, homebound Medicare recipients in Durham, North Carolina who have been high utilizers of health care resources. PHC integrates available personalized health technologies, standards of care, and personalized health planning to serve as a model for rational health care delivery. Importantly, the PHC model of care will serve as a market for emerging predictive and personalized technologies to foster genomic medicine.
References
[1]
Williams, R.S.; Willard, H.F.; Snyderman, R. Personalized health planning. Science 2003, 300, 549, doi:10.1126/science.300.5619.549.
[2]
Snyderman, R.; Williams, R.S. Prospective medicine: The next health care transformation. Acad. Med. 2003, 78, 1079–1084, doi:10.1097/00001888-200311000-00002.
Barnett, K.; Mercer, S.W.; Norbury, M.; Watt, G.; Wyke, S.; Guthrie, B. Epidemiology of multimorbidity and implications for health care, research, and medical education: A cross-sectional study. Lancet 2012, 380, 37–43.
[5]
Tinetti, M.E.; Fried, T.R.; Boyd, C.M. Designing health care for the most common chronic condition—Multimorbidity. JAMA 2012, 307, 2493–2494.
[6]
Salisbury, C. Multimorbidity: Redesigning health care for people who use it. Lancet 2012, 380, 7–9, doi:10.1016/S0140-6736(12)60482-6.
[7]
Montgomery, L. Good and Bad News for Medicare. The Washington Post 2011.
[8]
Dinan, M.A.; Simmons, L.A.; Snyderman, R. Commentary: Personalized health planning and the Patient Protection and Affordable Care Act: An opportunity for academic medicine to lead health care reform. Acad. Med. 2010, 85, 1665–1668, doi:10.1097/ACM.0b013e3181f4ab3c.
[9]
MLN Matters: Annual Wellness Visit (AWV), Including Personalized Prevention Plan Services (PPPS). Available online: http://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNMattersArticles/downloads/MM7079.pdf (accessed on 9 September 2012).
[10]
Simmons, L.A.; Dinan, M.A.; Robinson, T.J.; Snyderman, R. Personalized medicine is more than genomic medicine: Confusion over terminology impedes progress towards personalized health care. Pers. Med. 2012, 9, 85–91, doi:10.2217/pme.11.86.
[11]
Snyderman, R.; Dinan, M.A. Improving health by taking it personally. JAMA 2010, 303, 363–364, doi:10.1001/jama.2010.34.
[12]
Snyderman, R.; Yoediono, Z. Prospective care: A personalized, preventative approach to medicine. Pharmacogenomics 2006, 7, 5–9, doi:10.2217/14622416.7.1.5.
[13]
Yoediono, Z.; Snyderman, R. Proposal for a new health record to support personalized, predictive, preventative and participatory medicine. Pers. Med. 2008, 5, 47–54, doi:10.2217/17410541.5.1.47.
[14]
Hood, L.; Balling, R.; Auffray, C. Revolutionizing medicine in the 21(st) century through systems approaches. Biotechnol. J. 2012, 7, 992–1001, doi:10.1002/biot.201100306.
Smarr, L. Quantifying your body: A how-to guide from a systems biology perspective. Biotechnol. J. 2012, 7, 980–991, doi:10.1002/biot.201100495.
[17]
Snyderman, R. Personalized health care: From theory to practice. Biotechnol. J. 2012, 7, 973–979, doi:10.1002/biot.201100297.
[18]
Newgard, C.B.; An, J.; Bain, J.R.; Muehlbauer, M.J.; Stevens, R.D.; Lien, L.F.; Haqq, A.M.; Shah, S.H.; Arlotto, M.; Slentz, C.A.; et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 2009, 9, 311–326, doi:10.1016/j.cmet.2009.02.002.
[19]
Yaggy, S.D.; Michener, J.L.; Yaggy, D.; Champagne, M.T.; Silberberg, M.; Lyn, M.; Johnson, F.; Yarnall, K.S.H. Just for Us: An academic medical center-community partnership to maintain the health of a frail low-income senior population. Gerontologist 2006, 46, 271–276, doi:10.1093/geront/46.2.271.
[20]
Mark, D.B. An overview of risk assessment in coronary artery disease. Am. J. Cardiol. 1994, 73, 19–25, doi:10.1016/0002-9149(94)90261-5.
